105 related articles for article (PubMed ID: 3943037)
1. Toxicity associated with adjuvant postoperative therapy for adenocarcinoma of the rectum.
Thomas PR; Lindblad AS; Stablein DM; Knowlton AH; Bruckner HW; Childs DS; Mittelman A
Cancer; 1986 Mar; 57(6):1130-4. PubMed ID: 3943037
[TBL] [Abstract][Full Text] [Related]
2. Adjuvant postoperative radiotherapy and chemotherapy in rectal carcinoma: a review of the Gastrointestinal Tumor Study Group experience.
Thomas PR; Lindblad AS
Radiother Oncol; 1988 Dec; 13(4):245-52. PubMed ID: 3064191
[TBL] [Abstract][Full Text] [Related]
3. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
[TBL] [Abstract][Full Text] [Related]
4. Effective surgical adjuvant therapy for high-risk rectal carcinoma.
Krook JE; Moertel CG; Gunderson LL; Wieand HS; Collins RT; Beart RW; Kubista TP; Poon MA; Meyers WC; Mailliard JA
N Engl J Med; 1991 Mar; 324(11):709-15. PubMed ID: 1997835
[TBL] [Abstract][Full Text] [Related]
5. A quality-adjusted time without symptoms or toxicity (Q-TWiST) analysis of adjuvant radiation therapy and chemotherapy for resectable rectal cancer.
Gelber RD; Goldhirsch A; Cole BF; Wieand HS; Schroeder G; Krook JE
J Natl Cancer Inst; 1996 Aug; 88(15):1039-45. PubMed ID: 8683634
[TBL] [Abstract][Full Text] [Related]
6. Adjuvant postoperative fluorouracil-modulated chemotherapy combined with pelvic radiation therapy for rectal cancer: initial results of intergroup 0114.
Tepper JE; O'Connell MJ; Petroni GR; Hollis D; Cooke E; Benson AB; Cummings B; Gunderson LL; Macdonald JS; Martenson JA
J Clin Oncol; 1997 May; 15(5):2030-9. PubMed ID: 9164215
[TBL] [Abstract][Full Text] [Related]
7. Radiation therapy alone or in combination with chemotherapy in the treatment of residual or inoperable carcinoma of the rectum and rectosigmoid or pelvic recurrence following colorectal surgery. Radiation Therapy Oncology Group study (76-16).
Rominger CJ; Gunderson LL; Gelber RD; Conner N
Am J Clin Oncol; 1985 Apr; 8(2):118-27. PubMed ID: 3914838
[TBL] [Abstract][Full Text] [Related]
8. Randomized, multicenter, phase IIb study of preoperative chemoradiotherapy in T3 mid-distal rectal cancer: raltitrexed + oxaliplatin + radiotherapy versus cisplatin + 5-fluorouracil + radiotherapy.
Valentini V; Coco C; Minsky BD; Gambacorta MA; Cosimelli M; Bellavita R; Morganti AG; La Torre G; Trodella L; Genovesi D; Portaluri M; Maurizi-Enrici R; Barbera F; Maranzano E; Lupattelli M
Int J Radiat Oncol Biol Phys; 2008 Feb; 70(2):403-12. PubMed ID: 17919844
[TBL] [Abstract][Full Text] [Related]
9. Oxaliplatin added to fluorouracil-based preoperative chemoradiotherapy and postoperative chemotherapy of locally advanced rectal cancer (the German CAO/ARO/AIO-04 study): final results of the multicentre, open-label, randomised, phase 3 trial.
Rödel C; Graeven U; Fietkau R; Hohenberger W; Hothorn T; Arnold D; Hofheinz RD; Ghadimi M; Wolff HA; Lang-Welzenbach M; Raab HR; Wittekind C; Ströbel P; Staib L; Wilhelm M; Grabenbauer GG; Hoffmanns H; Lindemann F; Schlenska-Lange A; Folprecht G; Sauer R; Liersch T;
Lancet Oncol; 2015 Aug; 16(8):979-89. PubMed ID: 26189067
[TBL] [Abstract][Full Text] [Related]
10. Acute Adverse Events and Postoperative Complications in a Randomized Trial of Preoperative Short-course Radiotherapy Versus Long-course Chemoradiotherapy for T3 Adenocarcinoma of the Rectum: Trans-Tasman Radiation Oncology Group Trial (TROG 01.04).
Ansari N; Solomon MJ; Fisher RJ; Mackay J; Burmeister B; Ackland S; Heriot A; Joseph D; McLachlan SA; McClure B; Ngan SY
Ann Surg; 2017 May; 265(5):882-888. PubMed ID: 27631775
[TBL] [Abstract][Full Text] [Related]
11. Prolongation of the disease-free interval in surgically treated rectal carcinoma.
Gastrointestinal Tumor Study Group
N Engl J Med; 1985 Jun; 312(23):1465-72. PubMed ID: 2859523
[TBL] [Abstract][Full Text] [Related]
12. Radiation therapy and fluorouracil with or without semustine for the treatment of patients with surgical adjuvant adenocarcinoma of the rectum. Gastrointestinal Tumor Study Group.
J Clin Oncol; 1992 Apr; 10(4):549-57. PubMed ID: 1548520
[TBL] [Abstract][Full Text] [Related]
13. Prognostic factors for disease-free survival in patients with T3-4 or N+ rectal cancer treated with preoperative chemoradiation therapy, surgery, and intraoperative irradiation.
Díaz-González JA; Calvo FA; Cortés J; García-Sabrido JL; Gómez-Espí M; Del Valle E; Muñoz-Jiménez F; Alvarez E
Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1122-8. PubMed ID: 16406393
[TBL] [Abstract][Full Text] [Related]
14. Randomized trial of postoperative adjuvant therapy in stage II and III rectal cancer to define the optimal sequence of chemotherapy and radiotherapy: a preliminary report.
Lee JH; Lee JH; Ahn JH; Bahng H; Kim TW; Kang YK; Lee KH; Kim JC; Yu CS; Kim JH; Ahn SD; Kim WK; Kim SH; Lee JS
J Clin Oncol; 2002 Apr; 20(7):1751-8. PubMed ID: 11919231
[TBL] [Abstract][Full Text] [Related]
15. Preoperative radiochemotherapy and sphincter-saving resection for T3 carcinomas of the lower third of the rectum.
Rullier E; Goffre B; Bonnel C; Zerbib F; Caudry M; Saric J
Ann Surg; 2001 Nov; 234(5):633-40. PubMed ID: 11685026
[TBL] [Abstract][Full Text] [Related]
16. Pulmonary toxicity with combined modality therapy for limited stage small-cell lung cancer.
Brooks BJ; Seifter EJ; Walsh TE; Lichter AS; Bunn PA; Zabell A; Johnston-Early A; Edison M; Makuch RW; Cohen MH
J Clin Oncol; 1986 Feb; 4(2):200-9. PubMed ID: 3003259
[TBL] [Abstract][Full Text] [Related]
17. Intraoperative radiotherapy in the combination of adjuvant chemotherapy for the treatment of pT3N0M0 rectal cancer after radical surgery.
Zhang Q; Tey J; Yang Z; Li P; Peng L; Jiang R; Xiong F; Fu S; Lu JJ
Am J Clin Oncol; 2014 Feb; 37(1):8-12. PubMed ID: 22892433
[TBL] [Abstract][Full Text] [Related]
18. Can dosimetric parameters predict acute hematologic toxicity in rectal cancer patients treated with intensity-modulated pelvic radiotherapy?
Wan J; Liu K; Li K; Li G; Zhang Z
Radiat Oncol; 2015 Aug; 10():162. PubMed ID: 26238572
[TBL] [Abstract][Full Text] [Related]
19. Phase III trial of fluorouracil-based chemotherapy regimens plus radiotherapy in postoperative adjuvant rectal cancer: GI INT 0144.
Smalley SR; Benedetti JK; Williamson SK; Robertson JM; Estes NC; Maher T; Fisher B; Rich TA; Martenson JA; Kugler JW; Benson AB; Haller DG; Mayer RJ; Atkins JN; Cripps C; Pedersen J; Periman PO; Tanaka MS; Leichman CG; Macdonald JS
J Clin Oncol; 2006 Aug; 24(22):3542-7. PubMed ID: 16877719
[TBL] [Abstract][Full Text] [Related]
20. Combined modality therapy of rectal cancer: decreased acute toxicity with the preoperative approach.
Minsky BD; Cohen AM; Kemeny N; Enker WE; Kelsen DP; Reichman B; Saltz L; Sigurdson ER; Frankel J
J Clin Oncol; 1992 Aug; 10(8):1218-24. PubMed ID: 1634912
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
